7
Pale yellow liquid (0.054 g, 20%); 1H NMR (400 MHz,
CDCl3) δ: 7.29-7.19 (m, 3H), 6.93 (d, J = 8.4 Hz, 2H), 6.40 (d, J
= 8.4 Hz, 2H), 5.02 (br s, 1H), 3.23-3.16 (m, 2H), 2.22 (s, 3H),
1.13 (d, J = 6.8 Hz, 12H); 13C NMR (100 MHz, CDCl3) δ: 147.4,
145.9, 135.7, 129.8, 127.0, 126.9, 123.8, 113.1, 28.3, 23.9, 20.5.
6.68 (d, J = 9.2 Hz, 2H), 4.36 (s, 2H), 3.82 (s, 3H); 13C NMR
ACCEPTED MANUSCRIPT
(100 MHz, CDCl3) δ: 152.2, 142.6, 139.8, 128.7, 127.6, 127.3,
115.0, 114.2, 55.9, 49.3.
4.37. N-Benzylaniline (5mb).7b
Pale yellow solid (0.160 g, 87%); m.p. 34-35 oC; H NMR
1
4.28. 4-Fluoro-N-(p-tolyl)aniline (5bc).23
(400 MHz, CDCl3) δ: 7.48-7.43 (m, 4H), 7.40-7.36 (m, 1H), 7.28
(t, J = 8.0 Hz, 2H), 6.83 (t, J = 7.6 Hz, 1H), 6.73 (d, J = 8.0 Hz,
2H), 4.42 (s, 2H), 4.11 (br s, 1H); 13C NMR (100 MHz, CDCl3) δ:
148.3, 139.6, 129.4, 128.8, 127.6, 127.3, 117.7, 113.0, 48.4.
Pink solid (0.190 g, 94%); m.p. 49-50oC; 1H NMR (400 MHz,
CDCl3) δ: 7.14 (d, J = 8.0 Hz, 2H), 7.03-6.97 (m, 6H), 5.54 (br s,
1H), 2.37 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 157.7 (d, J =
237.7 Hz), 141.1, 139.8, 130.6, 130.0, 119.4 (d, J = 7.7 Hz),
117.9, 115.9 (d, J = 22.3 Hz), 20.7.
4.38. N-Benzyl-2-methylaniline (5me).26
Pale solid (0.110 g, 56%); m.p. 56-57 oC; 1H NMR (400 MHz,
CDCl3) δ: 7.53-7.47 (m, 4H), 7.44-7.40 (m, 1H), 7.26-7.21 (m,
2H), 6.82 (t, J = 7.4 Hz, 1H), 6.75 (d, J = 7.6 Hz, 1H), 4.50 (s,
2H), 3.99 (br s, 1H), 2.30 (s, 3H); 13C NMR (100 MHz, CDCl3) δ:
146.1, 139.6, 130.2, 128.8, 127.6, 127.3, 127.3, 122.0, 117.3,
110.0, 48.4, 17.7.
4.29. 2-Methyl-N-(p-tolyl)aniline (5be).23
1
Pink liquid (0.109 g, 55%); H NMR (400 MHz, CDCl3) δ:
7.24-7.12 (m, 5H), 6.98-6.91 (m, 3H), 5.35 (br s, 1H), 2.36 (s,
3H), 2.30 (s, 3H); 13C NMR (100 MHz, CDCl3) δ: 142.1, 141.1,
130.9, 129.9, 127.0, 126.8, 121.1, 118.7, 117.2, 20.7, 17.9.
4.30. 2-Methoxy-N-(p-tolyl)aniline (5bf).3d
4.39. N-Benzyl-2-methoxyaniline (5mf).26
1
Pink liquid (0.053 g, 25%); H NMR (400 MHz, CDCl3) δ:
Pale yellow liquid (0.059 g, 28%); 1H NMR (400 MHz,
CDCl3) δ: 7.38-7.31 (m, 4H), 7.27-7.24 (m, 1H), 6.85-6.77 (m,
2H), 6.69-6.65 (m, 1H), 6.58 (dd, J1 = 7.6 Hz, J2 = 1.2 Hz, 1H),
4.62 (br s, 1H), 4.34 (s, 2H), 3.83 (s, 3H); 13C NMR (100 MHz,
CDCl3) δ: 146.8, 139.6, 138.2, 128.6, 127.6, 127.2, 121.3, 116.7,
110.1, 109.4, 55.4, 48.1.
7.29-7.27 (m, 1H), 7.18-7.12 (m, 4H), 6.94-6.85 (m, 3H), 6.14
(br s, 1H), 3.94 (s, 3H), 2.37 (s, 3H); 13C NMR (100 MHz, CDCl3)
δ:147.9, 140.0, 133.9, 131.1, 129.9, 120.9, 119.7, 119.2, 113.7,
110.4, 55.6, 20.8.
4.31. 2-Ethyl-N-(p-tolyl)aniline (5bg).24
4.40. N-Benzyl-2-ethylaniline (5mg).27
Pink liquid (0.106 g, 50%); 1H NMR (400 MHz, CDCl3)
δ:7.29-7.24 (m, 2H), 7.20-7.12 (m, 3H), 7.02-6.94 (m, 3H), 5.39
(br s, 1H), 2.67 (q, J = 7.6 Hz, 2H), 2.36 (s, 3H), 1.32 (t, J = 7.6
Hz, 3H); 13C NMR (100 MHz, CDCl3) δ: 141.6, 141.4, 133.4,
130.2, 129.9, 128.9, 126.7, 121.7, 118.5, 118.3, 24.3, 20.7, 13.8.
Pale yellow liquid (0.106 g, 50%); 1H NMR (400 MHz,
CDCl3) δ: 7.55-7.49 (m, 4H), 7.45-7.42 (m, 1H), 7.28-7.25 (m,
2H), 6.89 (t, J = 7.4 Hz, 1H), 6.79 (d, J = 8.8 Hz, 1H), 4.52 (s,
2H), 4.11 (br s, 1H), 2.67 (q, J = 7.6 Hz, 2H), 1.43 (t, J = 7.6 Hz,
3H); 13C NMR (100 MHz, CDCl3) δ: 145.6, 139.8, 128.9, 128.0,
127.7, 127.4, 127.2, 117.6, 48.5, 24.1, 13.1.
4.32. N-Benzyl-4-methylaniline (5ma).25
Pale yellow liquid (0.164 g, 83%); 1H NMR (400 MHz,
CDCl3) δ: 7.45-7.28 (m, 5H), 7.06 (d, J = 8.4 Hz, 2H), 6.63 (d, J
= 8.4 Hz, 2H), 4.37 (s, 2H), 3.96 (br s, 1H), 2.32 (s, 3H); 13C
NMR (100 MHz, CDCl3) δ: 146.0, 139.7, 129.8, 128.7, 127.6,
127.2, 126.8, 113.1, 48.7, 20.5.
4.41. 1-(p-Tolyl)piperidine (5qa).3d
1
Colorless liquid (0.091 g, 52%); H NMR (400 MHz, CDCl3)
δ: 7.11 (d, J = 8.4 Hz, 2H), 6.91 (d, J = 8.8 Hz, 2H), 3.14 (t, J =
5.6 Hz, 4H), 2.31 (s, 3H), 1.79-1.73 (m, 4H), 1.63-1.57 (m, 2H);
13C NMR (100 MHz, CDCl3) δ: 150.3, 129.6, 128.8, 117.0, 51.4,
26.0, 24.3, 20.5.
4.33. N-Cyclohexyl-4-methylaniline (5na).3d
Pale yellow liquid (0.143 g, 75%); 1H NMR (400 MHz,
CDCl3) δ: 7.05 (d, J = 8.4 Hz, 2H), 6.60 (d, J = 8.4 Hz, 2H),
3.33-3.26 (m, 1H), 2.31 (s, 3H), 2.15-2.11 (m, 2H), 1.86-1.80 (m,
2H), 1.75-1.70 (m, 1H), 1.49-1.39 (m, 2H), 1.35-1.15 (m, 3H);
13C NMR (100 MHz, CDCl3) δ: 145.2, 129.8, 126.1, 113.5, 52.1,
33.6, 26.1, 25.1, 20.5.
4.42. 1-(4-Fluorophenyl)piperidine (5qc).28
Pale yellow liquid (0.088 g, 49%); 1H NMR (400 MHz,
CDCl3) δ: 7.00-6.90 (m, 4H), 3.09 (t, J = 5.4 Hz, 4H), 1.78-1.72
(m, 4H), 1.62-1.56 (m, 2H); 13C NMR (100 MHz, CDCl3) δ:
157.0 (d, J = 236.9 Hz), 149.1, 118.4 (d, J = 7.5 Hz), 115.4 (d, J
= 21.8 Hz), 51.9, 26.0, 24.1.
4.34. N-Butyl-4-methylaniline (5pa).24
4.43. 1-(4-Methoxyphenyl)piperidine (5qd).3f
1
Pale liquid (0.135 g, 82%); H NMR (400 MHz, CDCl3) δ:
7.03 (d, J = 8.0 Hz, 2H), 6.59 (d, J = 8.4 Hz, 2H), 3.13 (t, J = 7.2
Hz, 2H), 2.29 (s, 3H), 1.68-1.60 (m, 2H), 1.52-1.43 (m, 2H), 1.00
(t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ: 146.3, 129.7,
126.3, 112.9, 44.1, 31.8, 20.4, 20.4, 14.0.
Pale yellow liquid (0.105 g, 55%); 1H NMR (400 MHz, CDCl3) δ:
6.98-6.94 (m, 2H), 6.89-6.85 (m, 2H), 3.80 (s, 3H), 3.06 (t, J =
5.4 Hz, 4H), 1.79-1.73 (m, 4H), 1.61-1.55 (m, 2H); 13C NMR
(100 MHz, CDCl3) δ: 153.7, 146.7, 118.9, 114.3, 55.5, 52.5, 26.1,
24.2.
4.35. N-Benzyl-4-fluoroaniline (5mc).26
Acknowledgments
Pale yellow liquid (0.157 g, 78%); 1H NMR (400 MHz,
CDCl3) δ: 7.42-7.29 (m, 5H), 6.94 (t, J = 8.8 Hz, 2H), 6.63-6.60
(m, 2H), 4.34 (s, 2H), 3.98 (br s, 1H); 13C NMR (100 MHz,
CDCl3) δ: 155.9 (d, J = 233.6 Hz), 144.5, 139.3, 128.7, 127.5,
127.4, 115.7 (d, J = 22.3 Hz), 113.7 (d, J = 7.4 Hz), 48.9.
We are grateful for financial support provided by the National
Natural Science Foundation of China (21472041) and National
Key Technology R&D Program, the Ministry of Science and
Technology of China (2015BAK44B00).
4.36. N-Benzyl-4-methoxyaniline (5md).25
References and notes
1
Pale yellow solid (0.162 g, 76%); m.p. 48-49 oC; H NMR
1. (a) Chan, D. M. T.; Monaco, K. L.; Wang, R.-P.; Winters, M. P.
Tetrahedron Lett. 1998, 39, 2933-2936. (b) Lam, P. Y. S.; Clark,
(400 MHz, CDCl3) δ: 7.47-7.34 (m, 5H), 6.87 (d, J = 9.2 Hz, 2H),